My Patient Solutions
My Patient Solutions is a tool designed to help you enter and manage your patient cases with Genentech Access Solutions. Our easy-to-use online database tool offers you:
- Rapid access to all patient case files for single and multi-office practices
- Online completion, submission, printing and saving of the Statement of Medical Necessity (SMN) form
- Easy enrollment for new cases, with your practice information automatically populated
- Email and online alerts for your open cases
- Notifications about the latest news and developments from Genentech Access Solutions
- Quick links to the forms you need most often
Note: Register to use My Patient Solutions to obtain your unique User Name and Password before accessing the tool.
How My Patient Solutions Works
Once you have logged in, you can take the following actions in My Patient Solutions:
- Find, sort and select a patient's open case record to view status and benefits investigation results.
- Find, sort and select any closed patient case in the database.
- Download and print any required forms for patient enrollment.
- Enroll new patients for your practice online:
- Your practice information is automatically populated in the SMN by My Patient Solutions
- If the patient is already in our database, the demographic information is automatically populated by My Patient Solutions
- To enroll a new patient, you need the patient's contact and demographic information, insurance information, clinician information, medical history, prescribed therapy, indication and ICD-9 code(s)
- Update information and quickly re-enroll existing patients.
- View online alerts related to your patients' cases.
- Sign up for email alerts related to your patients' cases.
- See the latest news and updates from Genentech Access Solutions.
To start using My Patient Solutions now, please click on the log-in button in the upper right-hand corner of this screen. After you reach the My Patient Solutions log-in screen, you can click "Register Now" to request an account.
Pulmozyme (dornase alfa) Inhalation Solution Important Information
Indication and Usage
Daily administration of Pulmozyme in conjunction with standard therapies is indicated in the management of cystic fibrosis (CF) patients to improve pulmonary function. In patients with an FVC 
40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics.
Safety and efficacy of daily administration have not been demonstrated in patients for longer than 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its ingredients. Pulmozyme should be used in conjunction with standard therapies for CF. When starting Pulmozyme therapy, patients may experience change in or loss of voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose. These side effects are usually mild and short-lived.
For further information, please see the Pulmozyme full Prescribing Information. If you have questions, please discuss them with your CF health care team.
Pulmozyme® is a registered trademark and the Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.
